These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

209 related items for PubMed ID: 10098739

  • 1. In vitro radiosensitivity of tumour cells and fibroblasts derived from head and neck carcinomas: mutual relationship and correlation with clinical data.
    Stausbøl-Grøn B, Bentzen SM, Jørgensen KE, Nielsen OS, Bundgaard T, Overgaard J.
    Br J Cancer; 1999 Mar; 79(7-8):1074-84. PubMed ID: 10098739
    [Abstract] [Full Text] [Related]

  • 2. Selective assessment of in vitro radiosensitivity of tumour cells and fibroblasts from single tumour biopsies using immunocytochemical identification of colonies in the soft agar clonogenic assay.
    Stausbøl-Grøn B, Nielsen OS, Møller Bentzen S, Overgaard J.
    Radiother Oncol; 1995 Nov; 37(2):87-99. PubMed ID: 8747932
    [Abstract] [Full Text] [Related]

  • 3. Relationship between tumour cell in vitro radiosensitivity and clinical outcome after curative radiotherapy for squamous cell carcinoma of the head and neck.
    Stausbøl-Grøn B, Overgaard J.
    Radiother Oncol; 1999 Jan; 50(1):47-55. PubMed ID: 10225557
    [Abstract] [Full Text] [Related]

  • 4. Characterization and radiosensitivity of fibroblasts derived from squamous cell carcinomas of the head and neck, and the surrounding oral mucosa.
    Stausbøl-Grøn B, Bentzen SM, Overgaard J.
    Acta Oncol; 1998 Jan; 37(7-8):697-700. PubMed ID: 10050990
    [Abstract] [Full Text] [Related]

  • 5. The lack of correlation between proliferation (Ki-67, PCNA, LI, Tpot), p53 expression and radiosensitivity for head and neck cancers.
    Björk-Eriksson T, West CM, Cvetskovska E, Svensson M, Karlsson E, Magnusson B, Slevin NJ, Edström S, Mercke C.
    Br J Cancer; 1999 Jul; 80(9):1400-4. PubMed ID: 10424742
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Tumour cell proliferation under hypoxic conditions in human head and neck squamous cell carcinomas.
    Wijffels KI, Marres HA, Peters JP, Rijken PF, van der Kogel AJ, Kaanders JH.
    Oral Oncol; 2008 Apr; 44(4):335-44. PubMed ID: 17689286
    [Abstract] [Full Text] [Related]

  • 9. Does skin fibroblast radiosensitivity predict squamous cancer cell radiosensitivity of the same individual?
    Haikonen J, Rantanen V, Pekkola K, Kulmala J, Grénman R.
    Int J Cancer; 2003 Mar 01; 103(6):784-8. PubMed ID: 12516099
    [Abstract] [Full Text] [Related]

  • 10. Acute and late toxicity, tumour control and intrinsic radiosensitivity of primary fibroblasts in vitro of patients with advanced head and neck cancer after concomitant boost radiochemotherapy.
    Rudat V, Dietz A, Nollert J, Conradt C, Weber KJ, Flentje M, Wannenmacher M.
    Radiother Oncol; 1999 Dec 01; 53(3):233-45. PubMed ID: 10660204
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The in vitro radiosensitivity of human head and neck cancers.
    Björk-Eriksson T, West CM, Karlsson E, Slevin NJ, Davidson SE, James RD, Mercke C.
    Br J Cancer; 1998 Jun 01; 77(12):2371-5. PubMed ID: 9649161
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Fibroblast radiosensitivity in vitro and lung fibrosis in vivo: comparison between a fibrosis-prone and fibrosis-resistant mouse strain.
    Dileto CL, Travis EL.
    Radiat Res; 1996 Jul 01; 146(1):61-7. PubMed ID: 8677299
    [Abstract] [Full Text] [Related]

  • 17. Fibroblast radiosensitivity measured using the comet DNA-damage assay correlates with clonogenic survival parameters.
    Eastham AM, Marples B, Kiltie AE, Orton CJ, West CM.
    Br J Cancer; 1999 Mar 01; 79(9-10):1366-71. PubMed ID: 10188877
    [Abstract] [Full Text] [Related]

  • 18. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
    Lauve A, Morris M, Schmidt-Ullrich R, Wu Q, Mohan R, Abayomi O, Buck D, Holdford D, Dawson K, Dinardo L, Reiter E.
    Int J Radiat Oncol Biol Phys; 2004 Oct 01; 60(2):374-87. PubMed ID: 15380569
    [Abstract] [Full Text] [Related]

  • 19. Tumour vascularity is a significant prognostic factor for cervix carcinoma treated with radiotherapy: independence from tumour radiosensitivity.
    Cooper RA, West CM, Wilks DP, Logue JP, Davidson SE, Roberts SA, Hunter RD.
    Br J Cancer; 1999 Sep 01; 81(2):354-8. PubMed ID: 10496365
    [Abstract] [Full Text] [Related]

  • 20. Radiosensitivity in vitro of clonogenic and non-clonogenic glioblastoma cells obtained from a human brain tumour.
    Buronfosse A, Thomas CP, Ginestet C, Doré JF.
    C R Acad Sci III; 1994 Nov 01; 317(11):1031-41. PubMed ID: 7882140
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.